Search

Hepatoid adenocarcinoma (HAC) is defined as an extrahepatic tumor with hepatocyte differentiation. Hepatoid adenocarcinoma of the stomach (HAS) is a rare type of gastric cancer characterized by unique clinico-pathological features and a poor prognosis. We report a case of a metastatic HAS with a review of the literature.

International audience; Purpose/Objective The overall survival (OS) of patients (pts) with non-resectable locally advanced non-small cell lung carcinoma (LA-NSCLC) is poor, in part due to insufficient local control (LC) using conformal irradiation techniques (RT). The personalization of the RT margins may impact the LC and the outcome. Internal Target Volume strategy (ITV) versus "Mid-position" strategy (Mid-p), was compared in a prospective non-comparative randomized monocentric phase II trial in NSCLC patients treated by definitive radiotherapy. Planning Target volumes and mean lung dose were previously reported as significantly reduced using the Mid-p strategy (DOI: 10.1259/bjr.20190692). We report here the clinical results. Material and Methods Eligible patients were randomized (2:1) to be treated with Mid-p or ITV strategies. Patients with proven LA-NSCLC, non-resected, non-metastatic treated by definitive RT could be included. The main objective was to evaluate the 1-year progression-free-survival (PFS) rate in the two arms. 36 pts were planned in the Mid-p arm, Fleming single-stage design (1-sided =0.1, 80% power, P0=30%, P1=50%). Secondary objectives were to evaluate 1-y and 2-y LC, OS and acute/middle term toxicity (NCI-CTCAE v4).Results 54 pts were randomized from 09/12 to 05/18. 3 patients finally did not receive radiotherapy and were excluded from the analysis. Median age was 65.2 y, 2/3 of the patients were male and had IIIA NSCLC stages, 31% received concomitant chemotherapy. 34 pts and 17 pts were included in the analysis in the Mid-p arm and ITV arm respectively. Median RT dose was 66 Gy in the Mid-p arm and 62 Gy in the ITV arm. Median PFS were 9.3 months and 10.3 months in the Mid-p arm and ITV arms respectively. 1-year PFS rate were 38% (1-sided CI95% = 25-) and 47% (CI95% = [27;[) in the Mid-p/ITV arm respectively. Efficacy in Mid-p arm is below that expected (starting hypothesis p0=30%, p1=50%). 2-year PFS rates were 15% (Mid-p) and 12% (ITV). 2-years LC rates were 65% (CI95% [48;81]) and 76% (CI95% [53;94]) in the Mid-p/ITV arms respectively. The analysis of the type of local failures (in field versus border of fields) is under analysis and will be available for the congress.No grade 4 or toxic deaths related to RT were reported. Grade 3 acute lung toxicity were reported in 12% and 23% in Mid-p and in ITV arms respectively. Grade 2 and Grade 3 late radiation fibrosis were reported in 29% and 15% respectively in the Mid-p arm, versus 23% and 29% using ITV strategy. Conclusion Two-year LC and PFS in LA-NSCLC seems similar in this non comparative Phase II randomized study using Mid-p or ITV strategies. The details of local relapses regarding RT fields and margins are under analysis and will be presented during the congress.Conflict of interest: this study was granted by Elekta.

A new gadolinium diphosphate [HGdP2O7 · 2 H2O] · NH3 was synthesized via a soft chemistry route from evaporation of aqueous solution. It crystallizes in the space group Pī with Z = 2 and the following unit cell dimensions: a = 6.4609(2), b = 6.9810(2), c = 9.813(4) Ǻ, α = 81.345(3), β = 80.547(3), γ = 88.430(3)°. IR spectroscopy confirmed the presence of P-OH group, and both ammonia and water molecule in the studied material. The thermal decomposition of [HGdP2O7 · 2 H2O] · NH3, as investigated by Controlled Rate Thermal Analysis, took place in three stages between -23 and 600 °C leading to the anhydrous salt HGdP2O7. The calcination of the synthesized product at 850 °C in a static air furnace allowed us to obtain the tetraphosphate Gd2P4O13. X-ray powder diffraction and infrared spectroscopy were used to identify these materials. The electrical properties of HGdP2O7 and Gd2P4O13 were investigated through impedance complex analysis. Modest conductivity has been observed in both materials at relatively medium temperature range. Activation energies of 0.62 and 1.21 eV, were deduced from the Arrhenius plots for HGdP2O7 and Gd2P4O13, respectively.

Nasopharyngeal carcinoma (NPC) is a common head and neck cancer. The involvement of the digestive tract is exceptional. Herein we report the case of a 32-year-old man who initially presented with a T3N3M0 NPC according to the 7th edition of American Joint Committee on Cancer (AJCC) tumor/node/metastasis (TNM) classifications. The patient had a complete response after a treatment based on radiotherapy and concomitant chemotherapy. Fifteen months later, he presented with digestive symptoms. After explorations, radiological and histological findings concluded to a duodenal relapse of his NPC To our knowledge, this is the first case of a duodenal metastasis of a NPC reported in the literature.

Chemotherapy is the only systemic treatment approved for pancreatic ductal adenocarcinoma (PDAC), with a selection of regimens based on patients' performance status and expected efficacy. The establishment of a potent stratification associated with chemotherapeutic efficacy could potentially improve prognosis by tailoring treatments., info:eu-repo/semantics/published

Background. Adult granulosa cell tumors (AGCTs) are the most common sex cord-stromal tumors. Unlike epithelial ovarian tumors, they occur in young women and are usually detected at an early stage. The aim of this study was to report the clinical and pathological characteristics of AGCT patients and to identify the prognostic factors. Methods. All cases of AGCTs, treated at Salah Azaïz Institute between 1995 and 2010, were retrospectively included. Kaplan-Meier’s statistical method was used to assess the relapse-free survival and the overall survival. Results. The final cohort included 31 patients with AGCT. The mean age was 53 years (35–73 years). Patients mainly presented with abdominal mass and/or pain (61%, n=19). Mean tumor size was 20 cm. The majority of patients had a stage I disease (61%, n=19). Two among 3 patients with stage IV disease had liver metastasis. Mitotic index was low in 45% of cases (n=14). Surgical treatment was optimal in almost all cases (90%, n=28). The median follow-up time was 14 years (1–184 months). Ten patients relapsed (32%) with a median RFS of 8.4 years (6.8–9.9 years). Mean overall survival was 13 years (11–15 years). Stage I disease and low-to-intermediate mitotic index were associated with a better prognosis in univariate analysis (resp., p=0.05 and p=0.02) but were not independent prognostic factors. Conclusion. GCTs have a long natural history with common late relapses. Hence, long active follow-up is recommended. In Tunisian patients, hepatic metastases were more frequent than occidental series. The prognosis remains good and initial staging at diagnosis is an important prognostic factor.